Conquering Oxygen Heterogeneity in Hepatocellular Carcinoma With a Dual‐Targeted Nanoplatform Integrating Type I Photodynamic Therapy/Starvation Therapy/Hypoxia‐Activated Chemotherapy (Aggregate, 2026)